Literature DB >> 7589263

Clonal structure of invasive Streptococcus pyogenes in Northern Scotland.

M Upton1, P E Carter, M Morgan, G F Edwards, T H Pennington.   

Abstract

We have used molecular techniques to characterize 51 group A streptococci from Scotland and 17 'serious disease' isolates from other countries, in order to establish the clonal structure of invasive Streptococcus pyogenes strains circulating between 1986 and 1993. Strains were grouped by restriction endonuclease analysis, pulsed field gel electrophoresis and ribotyping patterns, and were examined for the presence of alleles of the speA gene by polymerase chain reaction and DNA sequence analysis. Serious and fatal infections in Scotland were caused by several clones. One clone (9 of 51 strains) was M type 1 and possessed the speA gene allele 2. This was the clone previously identified as causing severe infection in the USA. Another clone (5 of 51 strains) was M type 3 and had speA gene allele 3. In view of the clear association of more than one clone with severe, invasive and fatal infections, horizontal gene exchange between genotypes merits further investigation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589263      PMCID: PMC2271403          DOI: 10.1017/s0950268800058362

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  DNA fingerprints of Streptococcus pyogenes are M type specific.

Authors:  P P Cleary; E L Kaplan; C Livdahl; S Skjold
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

3.  Streptococcus pyogenes bacteraemia in Cambridge--a review of 67 episodes.

Authors:  J Francis; R E Warren
Journal:  Q J Med       Date:  1988-08

4.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

5.  Disseminated intravascular coagulation associated with group A streptococcal infection in pregnancy.

Authors:  G R Swingler; M A Bigrigg; B G Hewitt; C A McNulty
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

6.  Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin).

Authors:  J M Musser; V Kapur; S Kanjilal; U Shah; D M Musher; N L Barg; K H Johnston; P M Schlievert; J Henrichsen; D Gerlach
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

7.  Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated.

Authors:  P Ispahani; F E Donald; A J Aveline
Journal:  J Infect       Date:  1988-01       Impact factor: 6.072

8.  Changing epidemiology of group A streptococcal infection in the USA.

Authors:  B Schwartz; R R Facklam; R F Breiman
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321

9.  Changes in the pattern of infection caused by Streptococcus pyogenes.

Authors:  E Gaworzewska; G Colman
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  9 in total

1.  Associations of Streptococcus suis serotype 2 ribotype profiles with clinical disease and antimicrobial resistance.

Authors:  S R Rasmussen; F M Aarestrup; N E Jensen; S E Jorsal
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

2.  Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland.

Authors:  M Upton; P E Carter; G Orange; T H Pennington
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Clonal diversity of Streptococcus mitis biovar 1 isolates from the oral cavity of human neonates.

Authors:  S Fitzsimmons; M Evans; C Pearce; M J Sheridan; R Wientzen; G Bowden; M F Cole
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995.

Authors:  B Beall; R Facklam; T Hoenes; B Schwartz
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

5.  Relatedness of Streptococcus canis from canine streptococcal toxic shock syndrome and necrotizing fasciitis.

Authors:  L M DeWinter; J F Prescott
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

6.  Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.

Authors:  M Upton; J R Tagg; P Wescombe; H F Jenkinson
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

7.  Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein.

Authors:  L M Mejia; K E Stockbauer; X Pan; A Cravioto; J M Musser
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

8.  Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.

Authors:  Philip A Wescombe; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

9.  Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.

Authors:  Philip A Wescombe; Mathew Upton; Karen P Dierksen; Nancy L Ragland; Senthuran Sivabalan; Ruth E Wirawan; Megan A Inglis; Chris J Moore; Glenn V Walker; Chris N Chilcott; Howard F Jenkinson; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.